Half-year report · HY
4881.TEDINET S100YWZ3
Period2026-01-01 → 2026-06-30
Filed2026-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 41
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥538m | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | −¥910m | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | −¥536m | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥1.6bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥897m | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥566m | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥897m | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥567m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.9bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥894m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥567m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | −¥894m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥2.1bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥2.0bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥3.0bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥434m | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥517m | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.7bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥1.5bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥644m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥830m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥236,000 | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥993,000 | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥993,000 | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥771m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥811m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥811m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-12.66 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-50.2 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.15 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 78.1% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.7% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.6% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 370
| Item | Context | Value | Unit |
|---|---|---|---|
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes regarding research and development expenses (text) | InterimDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | InterimDuration | Original text (Japanese)当社グループは、医薬品等の研究開発事業の単一セグメントであるため、記載を省略しております。 | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |